These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28301903)

  • 1. Characterizing the Severe Reactions of Parenteral Vitamin K1.
    Britt RB; Brown JN
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):5-12. PubMed ID: 28301903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylactoid reactions to vitamin K.
    Fiore LD; Scola MA; Cantillon CE; Brophy MT
    J Thromb Thrombolysis; 2001 Apr; 11(2):175-83. PubMed ID: 11406734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review.
    Riegert-Johnson DL; Volcheck GW
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):400-6. PubMed ID: 12392385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The severe adverse reaction to vitamin k1 injection is anaphylactoid reaction but not anaphylaxis.
    Mi YN; Ping NN; Xiao X; Zhu YB; Liu J; Cao YX
    PLoS One; 2014; 9(3):e90199. PubMed ID: 24594861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerability of a new vitamin K1 preparation for parenteral administration to adults: one case of anaphylactoid reaction.
    Havel M; Müller M; Graninger W; Kurz R; Lindemayr H
    Clin Ther; 1987; 9(4):373-9. PubMed ID: 3607819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding the optimal dose of vitamin K1 to treat vitamin K deficiency and to avoid anaphylactoid reactions.
    Mi YN; Ping NN; Li B; Xiao X; Zhu YB; Cao L; Ren JK; Cao YX
    Fundam Clin Pharmacol; 2017 Oct; 31(5):495-505. PubMed ID: 28407450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy.
    Shields RC; McBane RD; Kuiper JD; Li H; Heit JA
    Mayo Clin Proc; 2001 Mar; 76(3):260-6. PubMed ID: 11243272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous reactions associated with vitamin K1.
    Wilkins K; DeKoven J; Assaad D
    J Cutan Med Surg; 2000 Jul; 4(3):164-8. PubMed ID: 11003724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and safety of a new solution of vitamin K1(20) in children with cholestasis.
    Amédée-Manesme O; Lambert WE; Alagille D; De Leenheer AP
    J Pediatr Gastroenterol Nutr; 1992 Feb; 14(2):160-5. PubMed ID: 1593370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with anaphylactoid hypersensitivity to intravenous cyclosporine and subcutaneous phytonadione (vitamin K(1)).
    Riegert-Johnson DL; Kumar S; Volcheck GW
    Bone Marrow Transplant; 2001 Dec; 28(12):1176-7. PubMed ID: 11803365
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cutaneous hypersensitivity at the site of injection of vitamin K1].
    Moreau-Cabarrot A; Giordano-Labadie F; Bazex J
    Ann Dermatol Venereol; 1996; 123(3):177-9. PubMed ID: 8761778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004.
    Zinderman CE; Landow L; Wise RP
    J Vasc Surg; 2006 May; 43(5):1004-9. PubMed ID: 16678697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe complication to phytomenadione after intramuscular injection in woman in labor. Case report and review of literature.
    Anderson TH; Hindsholm KB; Fallingborg J
    Acta Obstet Gynecol Scand; 1989; 68(4):381-2. PubMed ID: 2618627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudoscleroderma secondary to phytomenadione (vitamin K1) injections: Texier's disease.
    Pang BK; Munro V; Kossard S
    Australas J Dermatol; 1996 Feb; 37(1):44-7. PubMed ID: 8936071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Cowboy's belt with revolver" scleroderma caused by vitamin K1 injections.
    Lembo S; Megna M; Balato A; Balato N
    G Ital Dermatol Venereol; 2012 Apr; 147(2):203-5. PubMed ID: 22481583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylactic shock and vitamin K1.
    de la Rubia J; Grau E; Montserrat I; Zuazu I; Payá A
    Ann Intern Med; 1989 Jun; 110(11):943. PubMed ID: 2719430
    [No Abstract]   [Full Text] [Related]  

  • 17. Anaphylactoid reaction considered ciprofloxacin related: a case report and literature review.
    Kelesidis T; Fleisher J; Tsiodras S
    Clin Ther; 2010 Mar; 32(3):515-26. PubMed ID: 20399988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose.
    Schmidt LE
    Clin Toxicol (Phila); 2013 Jul; 51(6):467-72. PubMed ID: 23697458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vitamin K1: an option to reduce warfarin's activity.
    Harrell CC; Kline SS
    Ann Pharmacother; 1995 Dec; 29(12):1228-32. PubMed ID: 8672826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudoscleroderma secondary to phytonadione (vitamin K1) injections.
    Pujol RM; Puig L; Moreno A; Pérez M; de Moragas JM
    Cutis; 1989 Apr; 43(4):365-8. PubMed ID: 2731442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.